Literature DB >> 24570958

Cholangiocarcinoma: increasing burden of classifications.

Vincenzo Cardinale1, Maria Consiglia Bragazzi1, Guido Carpino2, Alessia Torrice1, Alice Fraveto1, Raffaele Gentile1, Vincenzo Pasqualino1, Fabio Melandro3, Camilla Aliberti4, Carlo Bastianelli4, Roberto Brunelli4, Pasquale Bartolomeo Berloco3, Eugenio Gaudio5, Domenico Alvaro6.   

Abstract

Cholangiocarcinoma (CCA) is a very heterogeneous cancer from any point of view, including epidemiology, risk factors, morphology, pathology, molecular pathology, modalities of growth and clinical features. Given this heterogeneity, a uniform classification respecting the epidemiologic, pathologic and clinical needs is currently lacking. In this manuscript we discussed the different proposed classifications of CCA in relation with recent advances in pathophysiology and biology of this cancer.

Entities:  

Keywords:  Cholangiocarcinoma (CCA); biliary cancerogenesis; biliary tree stem/progenitor cells; cells of origin; extra-hepatic CCA; hepatic stem/progenitor cells; intra-hepatic CCA

Year:  2013        PMID： 24570958      PMCID： PMC3924690          DOI： 10.3978/j.issn.2304-3881.2013.10.02

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


  43 in total

1.  Biliary tree stem/progenitor cells in glands of extrahepatic and intraheptic bile ducts: an anatomical in situ study yielding evidence of maturational lineages.

Authors:  Guido Carpino; Vincenzo Cardinale; Paolo Onori; Antonio Franchitto; Pasquale Bartolomeo Berloco; Massimo Rossi; Yunfang Wang; Rossella Semeraro; Maurizio Anceschi; Roberto Brunelli; Domenico Alvaro; Lola M Reid; Eugenio Gaudio
Journal:  J Anat       Date:  2011-12-05       Impact factor: 2.610

2.  Cystic and papillary neoplasm involving peribiliary glands: a biliary counterpart of branch-type intraductal papillary mucinous [corrected] neoplasm?

Authors:  Yasuni Nakanuma; Yasunori Sato
Journal:  Hepatology       Date:  2012-06       Impact factor: 17.425

3.  Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type.

Authors:  Shinichi Aishima; Yousuke Kuroda; Yunosuke Nishihara; Tomohiro Iguchi; Kenichi Taguchi; Akinobu Taketomi; Yoshihiko Maehara; Masazumi Tsuneyoshi
Journal:  Am J Surg Pathol       Date:  2007-07       Impact factor: 6.394

4.  Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: a novel in vitro model to study tumor-stroma interactions.

Authors:  Marco Massani; Tommaso Stecca; Luca Fabris; Ezio Caratozzolo; Cesare Ruffolo; Alberto Furlanetto; Stuart Morton; Massimiliano Cadamuro; Mario Strazzabosco; Nicolò Bassi
Journal:  Oncol Rep       Date:  2013-06-26       Impact factor: 3.906

5.  Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas?

Authors:  Flavio G Rocha; Hwajeong Lee; Nora Katabi; Ronald P DeMatteo; Yuman Fong; Michael I D'Angelica; Peter J Allen; David S Klimstra; William R Jarnagin
Journal:  Hepatology       Date:  2012-08-27       Impact factor: 17.425

6.  Descriptive epidemiology of cholangiocarcinoma in Italy.

Authors:  Domenico Alvaro; Emanuele Crocetti; Stefano Ferretti; Maria Consiglia Bragazzi; Riccardo Capocaccia
Journal:  Dig Liver Dis       Date:  2009-12-22       Impact factor: 4.088

Review 7.  Human hepatic stem cell and maturational liver lineage biology.

Authors:  Rachael Turner; Oswaldo Lozoya; Yunfang Wang; Vincenzo Cardinale; Eugenio Gaudio; Gianfranco Alpini; Gemma Mendel; Eliane Wauthier; Claire Barbier; Domenico Alvaro; Lola M Reid
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

8.  Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis.

Authors:  F Moinfar; Y G Man; L Arnould; G L Bratthauer; M Ratschek; F A Tavassoli
Journal:  Cancer Res       Date:  2000-05-01       Impact factor: 12.701

Review 9.  Precancerous lesions of the biliary tree.

Authors:  F Callea; C Sergi; G Fabbretti; M Brisigotti; C Cozzutto; D Medicina
Journal:  J Surg Oncol Suppl       Date:  1993

10.  Human hepatic stem cells from fetal and postnatal donors.

Authors:  Eva Schmelzer; Lili Zhang; Andrew Bruce; Eliane Wauthier; John Ludlow; Hsin-lei Yao; Nicholas Moss; Alaa Melhem; Randall McClelland; William Turner; Michael Kulik; Sonya Sherwood; Tommi Tallheden; Nancy Cheng; Mark E Furth; Lola M Reid
Journal:  J Exp Med       Date:  2007-07-30       Impact factor: 14.307
View more
  26 in total

Review 1.  Pathology of intrahepatic cholangiocarcinoma.

Authors:  Sandrine Vijgen; Benoit Terris; Laura Rubbia-Brandt
Journal:  Hepatobiliary Surg Nutr       Date:  2017-02       Impact factor: 7.293

2.  miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth.

Authors:  Yuyan Han; Fanyin Meng; Julie Venter; Nan Wu; Ying Wan; Holly Standeford; Heather Francis; Cynthia Meininger; John Greene; Jerome P Trzeciakowski; Laurent Ehrlich; Shannon Glaser; Gianfranco Alpini
Journal:  J Hepatol       Date:  2016-02-24       Impact factor: 25.083

3.  Low expression of ARID1A correlates with poor prognosis in intrahepatic cholangiocarcinoma.

Authors:  Song-Zhu Yang; An-Qiang Wang; Juan Du; Jian-Tao Wang; Wei-Wei Yu; Qing Liu; Yan-Fang Wu; Shu-Guang Chen
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

Review 4.  The cholangiocyte primary cilium in health and disease.

Authors:  Adrian P Mansini; Estanislao Peixoto; Kristen M Thelen; Cesar Gaspari; Sujeong Jin; Sergio A Gradilone
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-06-15       Impact factor: 5.187

Review 5.  Cholangiocarcinoma - evolving concepts and therapeutic strategies.

Authors:  Sumera Rizvi; Shahid A Khan; Christopher L Hallemeier; Robin K Kelley; Gregory J Gores
Journal:  Nat Rev Clin Oncol       Date:  2017-10-10       Impact factor: 66.675

6.  Viral hepatitis B and C infections increase the risks of intrahepatic and extrahepatic cholangiocarcinoma: Evidence from a systematic review and meta-analysis.

Authors:  Jie-Hui Tan; Wan-Yan Zhou; Lei Zhou; Rong-Chang Cao; Guo-Wei Zhang
Journal:  Turk J Gastroenterol       Date:  2020-03       Impact factor: 1.852

Review 7.  Cholangiocarcinoma: from molecular biology to treatment.

Authors:  Ana F Brito; Ana M Abrantes; João C Encarnação; José G Tralhão; Maria F Botelho
Journal:  Med Oncol       Date:  2015-10-01       Impact factor: 3.064

Review 8.  Emerging molecular therapeutic targets for cholangiocarcinoma.

Authors:  Sumera Rizvi; Gregory J Gores
Journal:  J Hepatol       Date:  2017-04-05       Impact factor: 25.083

9.  Burden of illness for patients with cholangiocarcinoma in the United States: a retrospective claims analysis.

Authors:  Christina X Chamberlain; Elizabeth Faust; Debbie Goldschmidt; Nathan Webster; Audra N Boscoe; Dendy Macaulay; Mary Linton Peters
Journal:  J Gastrointest Oncol       Date:  2021-04

10.  FOXF1 as an Immunohistochemical Marker of Hilar Cholangiocarcinoma or Metastatic Pancreatic Ductal Adenocarcinoma. Single Institution Experience.

Authors:  Jan Hrudka; Zuzana Prouzová; Katarína Mydlíková; Kristína Jedličková; Michal Holešta; Adam Whitley; Lukáš Havlůj
Journal:  Pathol Oncol Res       Date:  2021-04-20       Impact factor: 3.201
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.